Secretome Therapeutics · Series A
Senior Scientist Process Development
Plano, TX
Posted 29 days ago· Oct 23

Biotechnology, Health Care, Medical, Therapeutics
Secretome Therapeutics raised $30M in a Series A announced on May 27, 2026, led by RA Capital Management, TEDCO, University System of Maryland Momentum Fund, Parent Project Muscular Dystrophy, HEST. Since then it has posted 6 roles (5 still open), the first 113 days after it. With 5 open roles it is hiring more than 20% of the 226 Series A startups on JustBacked (median: 9). In total it has raised $60.8M over 6 rounds from 6 investors.
From Secretome Therapeutics's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.
Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.
The bet: cells from neonatal donors can be made consistent and potent enough to treat rare heart disease at scale. If it pays off, cardiac cell therapy needs far fewer donors, and Secretome, a clinical-stage Dallas company, could set the standard. RA Capital Management and TEDCO backed its $30M Series A, bigger than six in ten rounds at its stage this half, and all four open roles are under 30 days old.
JustBacked's take, based on Secretome Therapeutics's own site and its funding and hiring data.
Hiring velocity
Where they're hiring
Secretome Therapeutics · Series A
Plano, TX
Posted 29 days ago· Oct 23
Secretome Therapeutics · Series A
Remote (United States)
Posted 45 days ago· Oct 6
Secretome Therapeutics · Series A
Dallas, TX
Posted 64 days ago· Sep 17
Secretome Therapeutics · Series A
Remote (United States)
Posted 64 days ago· Sep 17
Secretome Therapeutics · Series A
Dallas, TX
Posted 64 days ago· Sep 17
Source: secretometherapeutics.com, checked daily.